Objectives: To determine the seroprevalence of, and risk factors for, HTLV-I and HTLV-II
infection among HIV-infected women and women at high risk for HIV infection. Design …

Data from a continuing multiyear seroprevalence survey of human T-lymphotropic virus
types I or II (HTLV-I/II) among intravenous drug users in seven US locations were analyzed …

We surveyed for serologie evidence of either HIV-1 or HTLV-I/II infection in 387 male
veterans who entered into an inpatient drug treatment center. Serum was obtained after …

In this report, the results of seroepidemiologic studies of human T-lymphotropic virus type I
(HTLV-I) and type II (HTLV-II) infections in different population groups in Argentina have …

To determine whether coinfection with HTLV-II influences the course of HIV-1 infection, we
evaluated the progression from asymptomatic HIV infection (CDC group II) to persistent …

Background: To investigate the seroprevalence of HTLV-I infection among male and female
injecting drug users (IDUs). Methods: A cross-sectional study conducted in Salvador, Brazil …

Objective: To assess the prevalence of HTLV infection and its association with HIV and other
potential risk factors. Design and Setting: A cross-sectional survey and a case-control study …

Objective: To examine whether select bacterial infections are associated with HTLV-II
infection among injection drug users, we conducted a nested case control study within an …

Human T-cell lymphotropic virus type 1 (HTLV-I) status was assessed in 994 patients
attending a sexually transmitted disease (STD) clinic in Kingston, Jamaica, between …

Reports of laboratory abnormalities associated with HTLV-I and HTLV-II infection are
inconsistent. We assessed complete blood counts and selected serum chemistry measures …